HARMONY BIOSCIENCES HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $33.78 per share as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $33.78.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $34.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $33.56.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $33.38.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $33.78 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $34.00 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $33.56 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $33.38 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $33.36 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $33.36 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $32.48 10-K · filed 2026-02-24 | |
| 2024-09-30 | $32.49 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $32.26 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $32.25 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $32.47 10-K · filed 2025-02-25 | |
| 2023-09-30 | $32.55 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $32.50 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $32.32 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $30.90 10-K · filed 2024-02-22 | |
| 2022-09-30 | $29.15 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $28.63 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $28.29 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $22.53 10-K · filed 2023-02-21 | |
| 2021-09-30 | $21.76 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $21.32 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $20.90 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $17.66 10-K · filed 2022-02-28 | $17.58 10-K · filed 2021-03-25 |
| 2020-09-30 | $16.40 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $8.22 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |